eyeforpharma.com

Marketing

The future of pharma e-marketing

Challenges and opportunities for today’s pharmaceutical e-marketers abound.

(Jul 30, 2008)

Catching up pharma's commerical model

Rod Street, a services partner at IBM and speaker at eyeforpharma’s recent eMarketing Europe 2008 conference, says that although pharma’s commercial model has been undermined on a large scale, the industry will catch up, because it needs to.

(Jul 28, 2008)

Lessons in e-detailing

Janssen-Cilag has learned a lot about its customers through its use of e-detailing.

(Jul 28, 2008)

Deploying New Commercial Models: Lessons from the Field

Over the past few years, the concept of “New Commercial Models” (NCMs) has rapidly progressed from novel idea to overused buzzword in the pharmaceutical industry as leading companies strive to adapt their sales and marketing infrastructures to changing market realities.

(Jul 28, 2008)

What does the NHS really want?

Jul 1, 2008

I'm at the eyeforpharma Responding to NHS Change conference taking place in London which brings together pharma industry, the NHS and private healthcare to discuss the changes in the UK healthcare env

Are you too detail-oriented?

A recent study by TNS Healthcare indicates that while rep visits are still important to doctors, other services are gaining in value.

(Jun 27, 2008)

Roundtable session: Using the internet to communicate with patients

Joanne Shaw, the Chairman of Datapharm hosted a roundtable session at an eyeforpharma Patient Compliance and Communication Conference on 12th June, exploring the challenge for the pharmaceutical indus

(Jun 26, 2008)

The future of pharma marketing

The pharmaceutical industry has undergone significant changes and restructuring that have caused the sales force to downsize and reorganize, and research and development teams to reconsider the blockbuster approach to new drug development. With these changes, marketers must also change and adapt to new market realities.

(Jun 18, 2008)

Condition Branding

IMS is cooperating with business academia in order to combine the unique market insight of IMS with the conceptual innovations coming from the world’s top business professors.

(Jun 17, 2008)

America's Other Drug Problem...?

May 12, 2008

I am really looking forward to this year’s Patient Compliance summit. When I first started this project I was very confused.